High Accuracy Indicators of Androgen Suppression Therapy Failure for Prostate Cancer-A Modeling Study

Area of Science:

• Oncology
• Mathematical Biology
• Evolutionary Dynamics

Background:

• Prostate cancer poses a significant public health challenge.
• Treatment resistance is a major hurdle in long-term prostate cancer management.
• Tumor evolution under treatment complicates therapeutic strategies.

Purpose of the Study:

• To develop novel methods for predicting treatment failure in prostate cancer.
• To investigate the utility of an evolutionary model for understanding tumor dynamics.
• To identify early indicators of drug resistance.

Main Methods:

• Developed a mechanistic model based on Droop cell quota theory with an evolutionary interpretation.
• Analyzed patient data, including Prostate-Specific Antigen (PSA) and androgen levels, from a clinical trial.
• Utilized intermittent androgen deprivation therapy data for model validation.

Main Results:

• Two distinct indicators for predicting treatment failure were identified.
• The first indicator, derived from the evolutionary model, achieved 87.3% predictive accuracy.
• The second indicator, based on serum androgen and PSA data, showed 88.7% predictive accuracy.

Conclusions:

• The study demonstrates the feasibility of using evolutionary tumor dynamics models for prostate cancer management.
• Predictive indicators can aid clinicians in adjusting treatment strategies adaptively.
• Early prediction of resistance can optimize treatment combinations and improve patient outcomes.